Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...

The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for ...

The research also found that weight-loss medication is boosting men’s dating lives more than women’s. Men were more likely to ...

Depending on your overall health, you may be a candidate for one of the new GLP-1 drugs (Ozempic, Wegovy, Mounjaro ... true for people who’ve had orthopedic surgery. In one study, published in the ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

The study found that a combination of exercise, healthy diet and other behaviors led to cognitive benefits. How much intense ...

FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs.  But the drugs can leave some ...

Lifestyle interventions can slow cognitive decline in your 60s and 70s, according to a large randomized controlled trial.

Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.

Older adults at risk for dementia who engaged in a structured lifestyle intervention — involving exercise, social interaction and a healthy diet — boosted brainpower.

New research builds on previous evidence that diet, certain brain training exercises and physical activity can delay the decline of memory and other cognitive abilities.